Frélii, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 14, 2019 at 02:48 pm
Share
Frélii, Inc. Announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was USD 22,604 compared to USD 3,291 a year ago. Operating loss was USD 1.436 million compared to USD 2.223 million a year ago. Net loss was USD 1.437 million compared to USD 2.223 million a year ago.
For the half year, sales was USD 39,547 compared to USD 3,741 a year ago. Operating loss was USD 1.783 million compared to USD 3.050 million a year ago. Net loss was USD 1.785 million compared to USD 3.047 million a year ago.
Frelii, Inc. provides Web-based nutrition and fitness programs based on usersâ genetic data. The Company provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies usersâ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Companyâs site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The Company provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. It provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.
FRÉLII, INC. 
